News

b

b

Current News in Drug Discovery

RSS Nature Reviews Drug Discovery
  • Novel antimalarial passes key phase III test November 26, 2025
    Nature Reviews Drug Discovery, Published online: 26 November 2025; doi:10.1038/d41573-025-00193-wNovel antimalarial passes key phase III test
    Asher Mullard
  • Repairing spinal cord damage November 25, 2025
    Nature Reviews Drug Discovery, Published online: 25 November 2025; doi:10.1038/d41573-025-00196-7Repairing spinal cord damage
    Sarah Crunkhorn
  • Enhancing RNA stability November 25, 2025
    Nature Reviews Drug Discovery, Published online: 25 November 2025; doi:10.1038/d41573-025-00195-8Enhancing RNA stability
    Sarah Crunkhorn
  • Designing G-protein-selective allosteric modulators November 25, 2025
    Nature Reviews Drug Discovery, Published online: 25 November 2025; doi:10.1038/d41573-025-00197-6Designing G-protein-selective allosteric modulators
    Sarah Crunkhorn
  • A broad-spectrum snakebite antivenom November 25, 2025
    Nature Reviews Drug Discovery, Published online: 25 November 2025; doi:10.1038/d41573-025-00194-9A broad-spectrum snakebite antivenom
    Sarah Crunkhorn
  • Epigenetic editing: from concept to clinic November 24, 2025
    Nature Reviews Drug Discovery, Published online: 24 November 2025; doi:10.1038/s41573-025-01323-0Epigenetic editing has emerged as a powerful hit-and-run approach to precise modification of gene expression without altering the underlying DNA sequence. This Review explores the therapeutic potential of epigenetic editing, highlights tools and concepts, assesses challenges and considerations, discusses in vivo studies and examines approaches and […]
    Elizabeth A. Heller
  • Halda secures biggest induced-proximity deal yet, with J&J’s US$3 billion buy out November 21, 2025
    Nature Reviews Drug Discovery, Published online: 21 November 2025; doi:10.1038/d41573-025-00190-zHalda secures biggest induced-proximity deal yet, with J&J’s US$3 billion buy out
    Asher Mullard
  • Magnetic microrobots provide targeted drug delivery November 21, 2025
    Nature Reviews Drug Discovery, Published online: 21 November 2025; doi:10.1038/d41573-025-00192-xMagnetic microrobots provide targeted drug delivery
    Katie Kingwell

Vitreon America™ Launches Botanicopeia™ Database and Federal Government Services at NIH Festival+

 BETHESDA, MD, September 17, 2016 − Vitreon America, Inc.™ participated this week in the National Institute of Health (NIH) Intramural Research Program’s 30th Annual NIH Research Festival which was held September 15-16, 2016 at the NIH Bethesda, Maryland campus.

The Festival included plenary sessions, symposia, exhibits, poster sessions and tours designed to encourage sharing and learning about the exciting research taking place on NIH campus.

Vitreon America™ was selected by the Technical Sales Association (TSA) which sponsors the Research Festival Exhibit, to launch its state-of-the-art Phytochemical and Ethnobotanical database subscription services, Botanicopeia™.

Attending on behalf of Vitreon America™
were Michael Megginson, VP of Business Development (left) and Jorgen Sandberg,
CEO (right).

Vitreon America was pleased to see the interest from the NIH Institutions to utilize the Botanicopeia™ database subscriptions with many NIH researchers expressing interest in considering the Vitreon America Botanical Research Analytic services as well to optimize the Botanicopeia™ database.

Based on the NIH researchers feedback, Vitreon America has established a Botanicopeia™ database subscription service agreement and subscription service with botanical research analytic services through Marshall Communications Corporation, www.marshallcomm.com.

Vitreon America services are available through Marshall Communications Corporation (VOSB) on NIH’s Information Technology Acquisition and Assessment Center’s (NITAAC)- Government-wide Acquisition Contract (GWAC) vehicle. [Prime Contract Holder #HHSN316201500063W]

Vitreon America™ was established with the goal of commercializing their Botanicopeia™ database and botanical research analytic services for development of botanicals and phytochemicals in the creation of new medicinal products by Vitreon America Clients.

To find out more about our Services please contact us for assistance at 1-888-214-2584 or at info@vitreonamerica.com

About Vitreon America™

Vitreon AmericaTM was formed with the goal of disseminating their BotanicopeiaTM database to encourage the increased use of botanicals and phytochemicals in the creation of new medicines.

Contact Vitreon America, Inc.

Vitreon America Botanical Research Center @ Hopkins Johns Hopkins University

MCC 9601 Medical Center Drive, Suite 221
Rockville, Maryland 20850

+1-888-214-2584

j.shaver@advasur.com